{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:38:05Z","timestamp":1790768285378,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10940-4","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:15:10Z","timestamp":1745396110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of HIV low-level viremia with CD4 count recovery among persons living with HIV during antiretroviral therapy in Dehong Prefecture, Southwest China in 2008\u20132021: a longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hailiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"8","key":"10940_CR1","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","unstructured":"Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349\u201356.","journal-title":"Lancet HIV"},{"issue":"10","key":"10940_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/hiv.12878","volume":"21","author":"L Ryom","year":"2020","unstructured":"Ryom L, Cotter A, De Miguel R, B\u00e9guelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, et al. 2019 Update of the European AIDS clinical society guidelines for treatment of people living with HIV version 10.0. HIV Med. 2020;21(10):617\u201324.","journal-title":"HIV Med"},{"key":"10940_CR3","unstructured":"Guidelines for the Use of Antiretroviral Agents in. Adults and Adolescents with HIV [https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/guidelines-adult-adolescent-arv.pdf]"},{"key":"10940_CR4","unstructured":"Consolidated guidelines on the use. of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach - Second edition [https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/]"},{"issue":"2","key":"10940_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1473-3099(17)30681-3","volume":"18","author":"LE Hermans","year":"2018","unstructured":"Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WDF, Wensing AMJ. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018;18(2):188\u201397.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10940_CR6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1097\/QAD.0000000000002588","volume":"34","author":"SC Inzaule","year":"2020","unstructured":"Inzaule SC, Bertagnolio S, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, et al. The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa. AIDS. 2020;34(10):1559\u201366.","journal-title":"AIDS"},{"issue":"12","key":"10940_CR7","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/cid\/ciz129","volume":"69","author":"C Joya","year":"2019","unstructured":"Joya C, Won SH, Schofield C, Lalani T, Maves RC, Kronmann K, Deiss R, Okulicz J, Agan BK, Ganesan A. Persistent Low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure. Clin Infect Dis. 2019;69(12):2145\u201352.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10940_CR8","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciaa413","volume":"72","author":"O Elvstam","year":"2021","unstructured":"Elvstam O, Marrone G, Medstrand P, Treutiger CJ, Sonnerborg A, Gisslen M, Bjorkman P. All-Cause mortality and serious Non-AIDS events in adults with Low-level human immunodeficiency virus viremia during combination antiretroviral therapy: results from a Swedish nationwide observational study. Clin Infect Dis. 2021;72(12):2079\u201386.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"3","key":"10940_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/QAI.0000000000001678","volume":"78","author":"E Bernal","year":"2018","unstructured":"Bernal E, Gomez JM, Jarrin I, Cano A, Munoz A, Alcaraz A, Imaz A, Iribarren JA, Rivero M, Arazo P, et al. Low-Level viremia is associated with clinical progression in HIV-Infected patients receiving antiretroviral treatment. J Acquir Immune Defic Syndr. 2018;78(3):329\u201337.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10940_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/QAD.0b013e32833556f3","volume":"24","author":"A Guihot","year":"2010","unstructured":"Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, et al. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy. AIDS. 2010;24(4):614\u20137.","journal-title":"AIDS"},{"key":"10940_CR11","doi-asserted-by":"crossref","unstructured":"Aksak-W\u0105s BJ, Kowalska JD, Z\u0105bek P, Serwin K, Rafalska-Kosior M, Go\u0142\u0105b J, Chober D, Skonieczna-\u017bydecka K, Hackiewicz M, Parczewski M. Immune restoration affects 10-year survival in people living with HIV\/AIDS. HIV. 2023;24(3):325\u201334.","DOI":"10.1111\/hiv.13391"},{"issue":"1","key":"10940_CR12","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1080\/22221751.2020.1840928","volume":"9","author":"J Liu","year":"2020","unstructured":"Liu J, Wang L, Hou Y, Zhao Y, Dou Z, Ma Y, Zhang D, Wu Y, Zhao D, Liu Z, et al. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study. Emerg Microbes Infect. 2020;9(1):2550\u201361.","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10940_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/cid\/cit232","volume":"57","author":"M Helleberg","year":"2013","unstructured":"Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Clin Infect Dis. 2013;57(2):314\u201321.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"3","key":"10940_CR14","doi-asserted-by":"publisher","first-page":"e1001194","DOI":"10.1371\/journal.pmed.1001194","volume":"9","author":"J Young","year":"2012","unstructured":"Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, et al. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 2012;9(3):e1001194.","journal-title":"PLoS Med"},{"issue":"50","key":"10940_CR15","doi-asserted-by":"publisher","first-page":"19851","DOI":"10.1073\/pnas.0810032105","volume":"105","author":"M Catalfamo","year":"2008","unstructured":"Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, Rupert A, Baseler M, Tagaya Y, Roby G, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci U S A. 2008;105(50):19851\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10940_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/QAI.0b013e31821e9f21","volume":"57","author":"X Li","year":"2011","unstructured":"Li X, Margolick JB, Jamieson BD, Rinaldo CR, Phair JP, Jacobson LP. CD4\u2009+\u2009T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2011;57(5):421\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10940_CR17","doi-asserted-by":"publisher","first-page":"20061","DOI":"10.7448\/IAS.18.1.20061","volume":"18","author":"N Ford","year":"2015","unstructured":"Ford N, Stinson K, Gale H, Mills EJ, Stevens W, P\u00e9rez Gonz\u00e1lez M, Markby J, Hill A. CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis. J Int AIDS Soc. 2015;18(1):20061.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"10940_CR18","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/QAD.0000000000002248","volume":"33","author":"N Pantazis","year":"2019","unstructured":"Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, Psichogiou M, Chini M, Sambatakou H, Sipsas NV, et al. Long-term evolution of CD4\u2009+\u2009cell count in patients under combined antiretroviral therapy. AIDS. 2019;33(10):1645\u201355.","journal-title":"AIDS"},{"issue":"10","key":"10940_CR19","first-page":"1437","volume":"36","author":"SC Inzaule","year":"2022","unstructured":"Inzaule SC, Kroeze S, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, et al. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis. AIDS. 2022;36(10):1437\u201347.","journal-title":"AIDS"},{"issue":"12","key":"10940_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/JCMA.0000000000000812","volume":"85","author":"CT Lee","year":"2022","unstructured":"Lee CT, Chen HP, Lin HH, Ke MY, Wu PF. The influence of low-level viremia on CD4\u2009+\u2009cell count in human immunodeficiency virus-infected patients. J Chin Med Assoc. 2022;85(12):1126\u201330.","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"10940_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jinf.2021.12.034","volume":"84","author":"Y Hou","year":"2022","unstructured":"Hou Y, Liu J, Zhao Y, Wu Y, Ma Y, Zhao D, Dou Z, Liu Z, Shi M, Jiao Y, et al. Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005\u20132018. J Infect. 2022;84(3):400\u20139.","journal-title":"J Infect"},{"issue":"1","key":"10940_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/hiv.13320","volume":"24","author":"H Yu","year":"2023","unstructured":"Yu H, Yang Y, Cao D, Zhao Y, Jin C, Sun H, Cao Y, Ye R, Yao S, Duan S, et al. Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study. HIV Med. 2023;24(1):37\u201345.","journal-title":"HIV Med"},{"issue":"12","key":"10940_CR23","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2352-3018(17)30131-5","volume":"4","author":"Z Wu","year":"2017","unstructured":"Wu Z, Tang Z, Mao Y, Van Veldhuisen P, Ling W, Liu D, Shen Z, Detels R, Lan G, Erinoff L, et al. Testing and linkage to HIV care in China: a cluster-randomised trial. Lancet HIV. 2017;4(12):e555\u201365.","journal-title":"Lancet HIV"},{"issue":"1","key":"10940_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/ciy400","volume":"68","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wu Z, McGoogan JM, Sha Y, Zhao D, Ma Y, Brookmeyer R, Detels R, Montaner JSG. Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011\u20132015. Clin Infect Dis. 2019;68(1):43\u201350.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"7","key":"10940_CR25","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Res. 2018;27(7):2015\u201323.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10940_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/QAI.0000000000001466","volume":"76","author":"T Yuen","year":"2017","unstructured":"Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, Letendre S, Heaton R, Mayo N. Personalized risk index for neurocognitive decline among people with Well-Controlled HIV infection. J Acquir Immune Defic Syndr. 2017;76(1):48\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10940_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Ann Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Ann Rev Clin Psychol"},{"issue":"1","key":"10940_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3851\/IMP2670","volume":"19","author":"S Kanters","year":"2014","unstructured":"Kanters S, Nachega J, Funk A, Mukasa B, Montaner JS, Ford N, Bucher HC, Mills EJ. CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis. Antivir Ther. 2014;19(1):31\u20139.","journal-title":"Antivir Ther"},{"issue":"9","key":"10940_CR29","doi-asserted-by":"publisher","first-page":"e25585","DOI":"10.1002\/jia2.25585","volume":"23","author":"R Handoko","year":"2020","unstructured":"Handoko R, Colby DJ, Kroon E, Sacdalan C, de Souza M, Pinyakorn S, Prueksakaew P, Munkong C, Ubolyam S, Akapirat S, et al. Determinants of suboptimal CD4(+) T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV-1 infection. J Int AIDS Soc. 2020;23(9):e25585.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10940_CR30","doi-asserted-by":"publisher","first-page":"e0265740","DOI":"10.1371\/journal.pone.0265740","volume":"17","author":"T Fiseha","year":"2022","unstructured":"Fiseha T, Ebrahim H, Ebrahim E, Gebreweld A. CD4\u2009+\u2009cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults. PLoS ONE. 2022;17(3):e0265740.","journal-title":"PLoS ONE"},{"issue":"2","key":"10940_CR31","doi-asserted-by":"publisher","first-page":"e84276","DOI":"10.1371\/journal.pone.0084276","volume":"9","author":"UR Montarroyos","year":"2014","unstructured":"Montarroyos UR, Miranda-Filho DB, C\u00e9sar CC, Souza WV, Lacerda HR, Albuquerque Mde F, Aguiar MF, Ximenes RA. Factors related to changes in CD4\u2009+\u2009T-cell counts over time in patients living with HIV\/AIDS: a multilevel analysis. PLoS ONE. 2014;9(2):e84276.","journal-title":"PLoS ONE"},{"issue":"3","key":"10940_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/QAI.0000000000001913","volume":"80","author":"L Gras","year":"2019","unstructured":"Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, et al. Determinants of restoration of CD4 and CD8 cell counts and their ratio in HIV-1-Positive individuals with sustained virological suppression on antiretroviral therapy. J Acquir Immune Defic Syndr. 2019;80(3):292\u2013300.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"10940_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/hiv.13250","volume":"23","author":"H Ding","year":"2022","unstructured":"Ding H, Xu J, Liu J, Wang Q, Kang J, Li X, Zhang Z, Han X, Jiang Y, Geng W, et al. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study. HIV Med. 2022;23(Suppl 1):64\u201371.","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"10940_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/hiv.13251","volume":"23","author":"R Bai","year":"2022","unstructured":"Bai R, Lv S, Hua W, Su B, Wang S, Shao Y, Li Z, Liu A, Sun L, Dai L. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China. HIV Med. 2022;23(Suppl 1):72\u201383.","journal-title":"HIV Med"},{"issue":"1","key":"10940_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12879-020-4837-y","volume":"20","author":"T Zhang","year":"2020","unstructured":"Zhang T, Ding H, An M, Wang X, Tian W, Zhao B, Han X. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort. BMC Infect Dis. 2020;20(1):147.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10940_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/QAD.0000000000000224","volume":"28","author":"Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe in EuroCoord","year":"2014","unstructured":"Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe in EuroCoord. Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals. AIDS. 2014;28(9):1351\u20136.","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10940-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10940-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10940-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:57:56Z","timestamp":1746172676000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10940-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10940"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10940-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4728431\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board (IRB) of the National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention (No. KX210330646), with individual-level informed consent waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"586"}}